Short-term treatment with deslorelin implants to improve the bucks’ ability to stimulate cyclic activity during the late non-breeding season

2020 ◽  
Vol 193 ◽  
pp. 106240
Author(s):  
Julia Giriboni ◽  
Özdal Gökdal ◽  
Okan Atay ◽  
Ali Kemali Özuğur ◽  
Güneş Erdoğan ◽  
...  
Author(s):  
Seniz Özis Altinçekiç ◽  
M. Koyuncu

The aim of the present paper was to investigate the efficiency of different progestagen treatment methods in combination with Pregnant Mare Serum Gonadotrophin (PMSG) in Merino ewes outside the breeding season. A total of 78 ewes (2 to 4 years old) with a mean bodyweight of 58.4 kg and an average body condition score (BCS) of 3.5 were used in the trial. The ewes were randomly divided into 3 equal groups [n= 26]. Intravaginal progestagen sponges containing Fluorogestone Acetate (FGA; 30 mg) were inserted intravaginally for different periods (7_days: short-term; 10_days: mid-term, 14_days: long-term). In all cases, 500 IU PMSG was administered intramuscularly at sponge withdrawal. The oestrus response, lambing rate, multiple birth rate, fecundity and litter size were [65.4, 61.5, 18.8 %, 0.77 and 1.25] in the short-term group; 80.8, 88.5, 34.8 %, 1.31 and 1.48 in the mid-term group; and 96.2, 92.3, 62.5 %, 1.50 and 1.63 in the long-term group, respectively. Oestrus manifestation and multiple birth rate were greater in long-term than in mid- and short-term groups, whereas for lambing rate, fecundity and litter size, better results were obtained in long- and mid-term than in short-term protocol. In conclusion, in Merino ewes, oestrus synchronisation outside the breeding season with long and mid-term progestagen treatment was found to be more effective than short-term treatment.


Author(s):  
TRISNI UNTARI DEWI ◽  
INSTIATY . ◽  
RUDIANTO SEDONO ◽  
GESTINA ALISKA ◽  
MUHAMMAD KHIFZHON AZWAR ◽  
...  

Objective: This study sought to determine the correlation between trough plasma amikacin concentrations and urinary normalized kidney injurymolecule-1 (KIM-1) concentrations as an early biomarker of nephrotoxicity in patients with sepsis who are hospitalized in an intensive care unit.Methods: In this pilot study, 12 patients with sepsis were treated with amikacin 1000 mg/day between May 2015 and September 2015. The correlationbetween trough plasma amikacin concentrations measured after the third dose and the elevation of urinary normalized KIM-1 concentrations afterthe third amikacin dose relative to the first/second dose was evaluated.Results: In total, three patients had trough plasma amikacin concentrations exceeding the safe level (>10 μg/ml). Furthermore, eight patientsdisplayed higher normalized KIM-1 concentrations after third dose than after the first/second dose; however, there was no correlation betweentrough amikacin concentrations and the elevation of urinary normalized KIM-1 concentrations (r=0.3, p=0.3).Conclusion: The study results illustrated that short-term treatment with an amikacin dose of 1000 mg/day was generally safe in patients with sepsis.


1997 ◽  
Vol 6 (4) ◽  
pp. 9-16 ◽  
Author(s):  
Alison Behrman ◽  
Robert F. Orlikoff

Sophisticated, computer-based instrumentation has become increasingly available to the voice clinician. Yet substantial questions remain regarding its clinical necessity and usefulness. A theoretical model based on the scientific method is developed as a framework that can be used to guide the clinician in the selection and application of instrumental measures. Using the process of hypothesis testing, instrumentation is presented as an integral component of clinical practice. The uses of instrumental measures, and their relevance to long- and short-term treatment goals, are addressed. Clinical examples are presented to illustrate the incorporation of instrumentation and the scientific method into assessment and treatment.


Sign in / Sign up

Export Citation Format

Share Document